Biocon licenses three generic formulation products to China Medical System Holdings EP News Bureau Sep 13, 2019 Under the terms of the agreement, Biocon will be responsible for the development, manufacturing and supply of the products…
Biocon-Mylan programmes make clinical progress Sanjiv Das May 7, 2015 PEG-G-CSF and Adalimumab enter phase II while patient recruitment for one insulin Glargine phase II study is complete Biocon has…
